General MedicationsTOPICALGeneric

HYTONE

HYDROCORTISONE

Standard Dose

2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview HYTONE is listed in Drugs@FDA under application 080474 (ANDA).

Marketing status: Discontinued Active ingredient HYDROCORTISONE Form and strength OINTMENT;TOPICAL - 2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor DERMIK LABS Submission history Latest submission status date: 1991-12-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview HYTONE is listed in Drugs@FDA under application 080474 (ANDA). Marketing status: Discontinued Active ingredient HYDROCORTISONE Form and strength OINTMENT;TOPICAL - 2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor DERMIK LABS Submission history Latest submission status date: 1991-12-09 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.